| Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review L Kassem, KS Shohdy, S Lasheen, O Abdel-Rahman, A Ali, ... Critical Reviews in Oncology/Hematology 134, 56-64, 2019 | 40 | 2019 |
| Toxoplasmosis an overlooked disease: seroprevalence in cancer patients RA Malek, R Wassef, E Rizk, H Sabry, N Tadros, A Boghdady Asian Pacific journal of cancer prevention: APJCP 19 (7), 1987, 2018 | 36 | 2018 |
| Predicting brain metastasis in breast cancer patients: stage versus biology HA Azim, R Abdel-Malek, L Kassem Clinical Breast Cancer 18 (2), e187-e195, 2018 | 28 | 2018 |
| The emerging treatment options of plasmablastic lymphoma: analysis of 173 individual patient outcomes NF Makady, D Ramzy, R Ghaly, RR Abdel-Malek, KS Shohdy Clinical Lymphoma Myeloma and Leukemia 21 (3), e255-e263, 2021 | 18 | 2021 |
| High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis HA Azim, L Santoro, RG Bociek, S Gandini, RA Malek, HA Azim Jr Annals of oncology 21 (5), 1064-1071, 2010 | 18 | 2010 |
| Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: Association with R-CHOP responsiveness MA Senousy, AM El-Abd, RR Abdel-Malek, SM Rizk Scientific Reports 11 (1), 2095, 2021 | 17 | 2021 |
| Availability of informal caregivers for palliative care patients with cancer: is there a difference between higher-and lower-income settings R Abdel-Malek, DE Farag, KS Shohdy, S Cox Indian journal of palliative care 25 (3), 379, 2019 | 17 | 2019 |
| Cimetidine a promising radio‐protective agent through modulating Bax/Bcl2 ratio: An in vivo study in male rats S Estaphan, R Abdel‐Malek, L Rashed, EA Mohamed Journal of Cellular Physiology 235 (11), 8495-8506, 2020 | 16 | 2020 |
| Validity of a new immunochromatographic test in detection of Toxoplasma gondii in cancer patients R Wassef, R Abdel-Malek Journal of parasitic diseases 43, 83-86, 2019 | 15 | 2019 |
| Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients HA Azim, RA Malek, AA Hatem Jr Women’s health 10 (5), 511-518, 2014 | 14 | 2014 |
| Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience WA Edesa, RR Abdel-malek Journal of the Egyptian National Cancer Institute 27 (2), 69-75, 2015 | 9 | 2015 |
| Efficacy and safety of cladribine: subcutaneous versus intravenous administration in hairy cell leukemia patients O Khorshid, AE Namour, MM El-Gammal, TY Mahmoud, C Fortpied, ... Mediterranean Journal of Hematology and Infectious Diseases 7 (1), 2015 | 9 | 2015 |
| Toxoplasmosis: an overlooked infection in cancer patients RM Wassef, RRA Malek, EM Rizk, AM Boghdady Annals of Oncology 27, vi479, 2016 | 6 | 2016 |
| Taxane-based regimens as adjuvant treatment for breast cancer: a retrospective study in egyptian cancer patients HA Azim, MM Mousa, RA Malek, MK Abdalmassih, NY Ibrahim Asian Pacific Journal of Cancer Prevention 16 (1), 65-69, 2015 | 6 | 2015 |
| Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma M Hasaballah, R Abdel-Malek, Z Zakaria, MS Marie, MS Naguib Journal of Gastrointestinal Oncology 9 (6), 1190, 2018 | 5 | 2018 |
| Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma … R Abdel-Malek, N Abbas, KS Shohdy, M Ismail, R Fawzy, DS Salem, ... Journal of the Egyptian National Cancer Institute 29 (3), 155-158, 2017 | 4 | 2017 |
| Prevalence of Enteric Opportunistic Parasites in Immunocompromised Cancer Patients R Wassef, E Rizk, R Abdel-Malek Open Forum Infectious Diseases 3 (suppl_1), 582, 2016 | 4 | 2016 |
| Bilateral phyllodes tumor of the breast; a case report of benign tumor on one side and malignant tumor on the contralateral side H Abdel Azim, O Abdel-Rahman, R Abdel-Malek Research in Oncology 13 (2), 56-58, 2017 | 3 | 2017 |
| CD38 Gene polymorphisms and susceptibility to B cell chronic lymphocytic leukemia TK Eyada, SK Hussein, SA Younan, WM Abd El Ghany, RA Malek Comparative Clinical Pathology 22, 573-579, 2013 | 3 | 2013 |
| Evaluation of target volume margins for radiotherapy of prostate implanted with fiducial markers R Fawzy, R Abdel-Malek, M Metwaly, O Abdelaziz, A Seleem Radiological Physics and Technology 13, 152-159, 2020 | 2 | 2020 |
